Search

everythinglearnresearchcommunity

for

Search:↓

The new LC-MS/MS method is more accurate and reliable than traditional immunoassays for measuring steroids in serum.

Patients with non-small-cell lung cancer need significant survival gains to accept severe side effects.

Autologous Cellular Micrografts effectively treat hair loss with significant improvements and no dangerous side effects.

Fluridil promotes hair growth safely and effectively for androgenetic alopecia.

PLD is an effective and safer alternative for treating breast cancer.

Baricitinib showed mixed results in treating alopecia areata in children, with some improvement but also side effects.

Long-term treatment with palbociclib plus letrozole maintains quality of life in certain breast cancer patients.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

Triamcinolone acetonide therapy for hair loss may cause a skin condition called linear lichen planus.

Some medications and supplements can cause serious side effects, including hair loss, heart rhythm problems, liver injury, and other health issues.

The CapilliCARE® machine shows promise for diagnosing early hair loss.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

A reliable method was developed to measure Finasteride and Tadalafil in rat blood.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

Precision neuromodulation may improve schizophrenia symptoms.

Metreleptin treatment significantly improved metabolic health in a boy with congenital generalized lipodystrophy.

The committee decided not to approve the drug due to low effectiveness and high risks.

The study's findings are unreliable due to retraction.

Topical immunotherapy with DPCP led to some hair regrowth in most pediatric alopecia areata patients, especially those with milder cases and longer treatment.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

A new peptide, murikal/SPR4, was found to significantly increase hair growth in mice, and its liposomal topical formulations enhanced hair growth more than commercial products. However, results on human scalp skin were unclear, needing more tests.

Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.

A new tool helps lupus patients and doctors better track symptoms and quality of life.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.